Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Three-dimensional IMRT verification with a flat-panel EPID.

S Steciw1, B Warkentin, S Rathee

  • 1Department of Medical Physics, Cross Cancer Institute, Edmonton, Alberta T6G IZ2, Canada.

Medical Physics
|March 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction: Minimal skin dose increase in longitudinal rotating biplanar linac-MR systems: examination of radiation energy and flattening filter design (2016<i>Phys. Med. Biol.</i>61 3527).

Physics in medicine and biology·2025
Same author

Seed size dimorphism in Hyptis suaveolens aids in differentiation of the germination niche.

Plant biology (Stuttgart, Germany)·2022
Same author

Feasibility of energy adaptive angular meshing for perpendicular and parallel magnetic fields in a grid based Boltzmann solver.

Biomedical physics & engineering express·2021
Same author

A novel transport sweep architecture for efficient deterministic patient dose calculations in MRI-guided radiotherapy.

Physics in medicine and biology·2019
Same author

Proton beam behavior in a parallel configured MRI-proton therapy hybrid: Effects of time-varying gradient magnetic fields.

Medical physics·2018
Same author

On the direct acquisition of beam's-eye-view images in MRI for integration with external beam radiotherapy.

Physics in medicine and biology·2018

A new 3D method verifies intensity-modulated radiotherapy (IMRT) by comparing electronic portal imaging device (EPID) doses with treatment planning system (TPS) calculations. This approach identifies significant dose calculation uncertainties in IMRT, improving treatment accuracy.

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Radiotherapy Verification

Background:

  • Intensity-modulated radiotherapy (IMRT) requires precise dose calculation for effective cancer treatment.
  • Current verification methods may not fully capture dose uncertainties in complex IMRT plans.
  • Electronic portal imaging devices (EPIDs) offer a potential tool for pretreatment dose verification.

Purpose of the Study:

  • To develop and validate a novel three-dimensional (3D) pretreatment verification technique for IMRT using EPID measurements.
  • To assess the accuracy of dose calculations from a treatment planning system (TPS) for IMRT.
  • To quantify potential underestimations in dose delivery and their clinical implications.

Main Methods:

  • Developed a 3D IMRT verification procedure using 2D primary fluence profiles measured by an amorphous silicon flat-panel EPID.

Related Experiment Videos

  • Extracted fluence profiles via deconvolution of EPID images using Monte Carlo-simulated kernels for 6 and 15 MV photons.
  • Inputted 2D fluence profiles into a TPS to generate 3D doses for comparison with planned doses and phantom measurements.

    • Main Results:

    • The EPID-based 3D dose distribution showed good agreement with thermoluminescent dosimeter (TLD) measurements in an anthropomorphic phantom.
    • The TPS underpredicted TLD measurements by approximately 16% in a high-gradient region.
    • Significant discrepancies were observed between EPID-based and TPS doses in water phantom profiles and clinical head and neck IMRT plans, with TPS underestimating doses to critical structures by ~4 Gy.

    Conclusions:

    • The developed 3D EPID-based method effectively quantifies uncertainties in TPS dose calculations for IMRT.
    • TPS dose calculations can underestimate delivered doses, particularly in high-gradient regions and for critical structures.
    • These dose underestimations may lead to clinically significant underpredictions of normal tissue complication rates, highlighting the need for improved verification strategies.